Credit Suisse Group Analysts Give Gerresheimer (GXI) a €72.00 Price Target

Credit Suisse Group set a €72.00 ($88.89) target price on Gerresheimer (ETR:GXI) in a research report report published on Monday. The brokerage currently has a buy rating on the stock.

A number of other research firms have also weighed in on GXI. Hauck & Aufhaeuser set a €55.00 ($67.90) target price on shares of Gerresheimer and gave the company a sell rating in a report on Wednesday, January 24th. Independent Research set a €74.00 ($91.36) target price on shares of Gerresheimer and gave the company a neutral rating in a report on Thursday, January 25th. Goldman Sachs set a €68.00 ($83.95) target price on shares of Gerresheimer and gave the company a neutral rating in a report on Thursday, January 25th. Deutsche Bank set a €66.00 ($81.48) target price on shares of Gerresheimer and gave the company a neutral rating in a report on Monday, January 22nd. Finally, equinet set a €75.00 ($92.59) target price on shares of Gerresheimer and gave the company a neutral rating in a report on Friday, January 19th. Two research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have issued a buy rating to the company. Gerresheimer has an average rating of Hold and an average price target of €67.96 ($83.90).

How to Become a New Pot Stock Millionaire

GXI stock opened at €66.90 ($82.59) on Monday. Gerresheimer has a fifty-two week low of €59.97 ($74.04) and a fifty-two week high of €78.25 ($96.60).

TRADEMARK VIOLATION WARNING: This story was posted by Week Herald and is the sole property of of Week Herald. If you are viewing this story on another site, it was illegally copied and reposted in violation of international copyright laws. The original version of this story can be viewed at https://weekherald.com/2018/04/19/credit-suisse-group-analysts-give-gerresheimer-gxi-a-72-00-price-target.html.

Gerresheimer Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply